Sign In
Buy BVXV
$1.36
+0 (+0%)
At Close: Dec 05, 2023
BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd.
06:00am, Wednesday, 06'th Sep 2023
Scinai Immunotherapeutics to debut tomorrow under Nasdaq ticker symbol “SCNI” Scinai Immunotherapeutics to debut tomorrow under Nasdaq ticker symbol “SCNI”
BiondVax Reports Second Quarter Financial Results and Provides Business Update
09:00am, Friday, 11'th Aug 2023
JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- via IBN - BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immuno
Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules
04:01pm, Tuesday, 01'st Aug 2023
JERUSALEM, Aug. 01, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative imm
BiondVax to Present at BIO-Europe Spring
01:10pm, Thursday, 16'th Mar 2023
JERUSALEM, March 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd . (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing
BiondVax Presenting at BIO CEO & Investor Conference
02:15pm, Thursday, 02'nd Feb 2023
JERUSALEM, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd . ( Nasdaq: BVXV ), a biotechnology company focused on developing, manufacturing, and commercializing inn
Best Penny Stocks To Buy? 5 To Watch After Big News This Week
09:28am, Monday, 23'rd Jan 2023
Penny stocks to watch with news that are turning heads in the stock market this week. The post Best Penny Stocks To Buy?
BiondVax CEO to Present at the January 2023 Biotech Showcase in San Francisco
06:00am, Monday, 21'st Nov 2022
JERUSALEM , Nov. 21, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) ("BiondVax"), a biotechnology company focused on developing, manufacturing, and commercializing innovative immun
BiondVax to present at Recent Advances in Fermentation Technology (RAFT) 14 Conference
11:30am, Thursday, 03'rd Nov 2022
JERUSALEM , Nov. 3, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) ("BiondVax"), a biotechnology company focused on developing, manufacturing, and commercializing innovative produc
BiondVax to Present at LD Micro Investor Conference in Los Angeles
07:55am, Tuesday, 18'th Oct 2022
Jerusalem, Israel--(Newsfile Corp. - October 18, 2022) - BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) ("BiondVax"), a biotechnology company focused on developing, manufacturing, and commercializing in
BiondVax to present at LD Micro Investor Conference in Los Angeles
02:00pm, Tuesday, 11'th Oct 2022
JERUSALEM , Oct. 11, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) ("BiondVax"), a biotechnology company focused on developing, manufacturing, and commercializing innovative produ
BiondVax to Present at H.C. Wainwright 24th Annual Global Investment Conference
09:13am, Thursday, 08'th Sep 2022
JERUSALEM , Sept. 8, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd.
BiondVax to Present at this week's Biomed Israel Conference
06:00am, Monday, 09'th May 2022
JERUSALEM , May 9, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the
BiondVax Pharmaceuticals Ltd. (BVXV) CEO Amir Reichman on Q4 2021 Results - Earnings Call Transcript
03:23pm, Monday, 04'th Apr 2022
BiondVax Pharmaceuticals Ltd. (BVXV) CEO Amir Reichman on Q4 2021 Results - Earnings Call Transcript
BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
07:00am, Monday, 28'th Mar 2022
JERUSALEM, March 28, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the
Why Is BiondVax (BVXV) Stock Up Today?
01:15pm, Thursday, 24'th Mar 2022
BVXV stock is climbing today on news that BiondVax has struck a deal to pursue a range of antibody treatments. Here's what to know.
